Condition: Multiple SclerosisIntervention: Diagnostic Test: Scale for the Assessment of Sensory Integration in AdultsSponsor: Pomeranian Medical University SzczecinCompleted Author:
Category: Clinical Trials
Information and news about current clinical trials
Manganese-Enhanced Magnetic Resonance Imaging in Healthy Volunteers and People With Multiple Sclerosis
Condition: Multiple SclerosisIntervention: Drug: Mangafodipir (Teslascan)Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)Completed Author:
Normobaric Hypoxic Training and Multiple Sclerosis
Condition: Multiple SclerosisInterventions: Other: Hypoxic training; Other: Normoxic trainingSponsor: Charite University, Berlin, GermanyCompleted Author:
Relating Genetic and Environmental Risk Scores to Multiple Sclerosis Susceptibility
Condition: Multiple SclerosisIntervention: Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)Completed Author:
Clinical Trial Assessing Temelimab Following Rituximab Treatment in Patients With Relapsing Forms of Multiple Sclerosis
Condition: Multiple SclerosisInterventions: Drug: temelimab 18 mg/kg; Drug: temelimab 36 mg/kg; Drug: temelimab 54 mg/kg; Drug: PlaceboSponsor: GeNeuro Innovation SASCompleted Author:
Impact of Core Performance on Functional Parameters in Multiple Sclerosis
Condition: Multiple SclerosisIntervention: Other: AssessmentSponsor: Istanbul University-CerrahpasaCompleted Author:
Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis
Conditions: Multiple Sclerosis; Exercise Program; Telerehabilitation; Autoimmune DisorderInterventions: Other: Fatigue Severity Scale; Other: Berg Balance Test; Other: Time up and go- 25 steps walking test; Other: Multiple Sclerosis Quality of Life; Other: Brief International Cognitive Assessment for MS (BICAMS); Other: Beck Depression and Anxiety ScaleSponsor: Muğla Sıtkı Koçman UniversityCompleted Author:
A Study to Evaluate the Safety and Efficacy of PTC518 in Participants With Huntington’s Disease (HD)
Condition: Huntington DiseaseInterventions: Drug: PTC518; Drug: PlaceboSponsor: PTC TherapeuticsRecruiting Author:
Enroll -HD: A Prospective Registry Study in a Global Huntington’s Disease Cohort
Condition: Huntington’s DiseaseIntervention: Sponsor: CHDI Foundation, Inc.Recruiting Author:
A Dose Range Finding Study With Open-Label Extension to Evaluate the Safety of Oral LMI070/Branaplam in Early Manifest Huntington’s Disease
Condition: Early Manifest Huntington DiseaseInterventions: Drug: Branaplam; Drug: PlaceboSponsor: Novartis PharmaceuticalsRecruiting Author:
A Study to Test if TEV-50717 is Safe and Effective in Relieving Abnormal Involuntary Movements in Cerebral Palsy
Condition: Cerebral Palsy, DyskineticIntervention: Drug: TEV-50717Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.Recruiting Author:
Individuals Patterns of Disclosure About Huntington s Disease (HD) and the Association With Adaptation to HD
Condition: Huntington’s DiseaseIntervention: Sponsor: National Human Genome Research Institute (NHGRI)Completed Author: